Sansure Biotech Inc is a renowned in vitro diagnostics companythat has been at the forefront of revolutionizing genetic testing. With their innovative gene technology as the core, Sansure has integrated diagnostic reagents, instruments, and independent clinical laboratory services to provide comprehensive diagnostic solutions.
Advanced Technologies and Products
Sansure has developed a wide range of internationally leading core technologies and over 500 products that surpass the advanced level both domestically and internationally. These groundbreaking technologies have not only propelled the domestic industry to catch up with international standards but have also broken the monopoly of imports. Sansure’s commitment to promoting the application of gene technology across various medical institutions and scenarios is commendable.
During the early days of the COVID 19 pandemic, Sansure played a pivotal role in combating the virus by successfully developing new nucleic acid detection reagents and rapid detection instruments. Their SARS-CoV-2 nucleic acid test has been deployed in over 160 countries and regions worldwide.
Sansure Biotech Inc’s contributions to the field of genetic testing have not gone unnoticed. The company is honored to be recognized as a National Demonstration Centre for the Application of Genetic Testing Technology and a National Joint Local Engineering Research Center for Genetic Diagnosis of Infectious Diseases and Tumors. These accolades highlight Sansure’s commitment to advancing genetic diagnostics and further solidify their position as a leading in vitro diagnostics company.
Sansure Biotech Inc’s innovative gene technology and commitment to global health make them a prominent player in the field of in vitro diagnostics. Their groundbreaking technologies and dedication to advancing genetic testing have not only impacted the domestic industry but have also made a significant global impact. As an in vitro diagnostics company, Sansure continues to pave the way for the future of genetic testing.